Literature DB >> 11118052

Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer.

H A Pulido1, M J Fakruddin, A Chatterjee, E D Esplin, N Beleño, G Martinez, H Posso, G A Evans, V V Murty.   

Abstract

Previous functional and deletion mapping studies on cervical cancer (CC) have implicated one or more tumor suppressor genes (TSGs) on chromosome 11 at q13 and q22-24 regions. Of these, the 11q22-24 region exhibits frequent allelic deletions in a variety of solid tumor types, suggesting the presence of critical genes for tumor suppression in this region. However, the precise region of deletion on 11q is not clearly defined in CC. In an attempt to accurately map the deleted region, we performed an extensive loss of heterozygosity (LOH) mapping in 58 tumors using 25 polymorphic loci on both the short and long arms. The pattern of LOH identified three sites of deletions, two on 11p (p15.11-p15.3 and p12-13), and one on 11q (q23.1-q23.2). The 11q23.1-q23.2 exhibited highest frequency (60.6%) of deletions, suggesting that this could be the site of a candidate TSG in CC. The minimal deletion at 11q23.1-23.2 was restricted to a 6-cM region between 123.5 and 129.5 cM genetic distance on chromosome 11, identifying the site of a potential TSG important in the pathogenesis of CC. At least five known genes and 28 UniGene clusters were mapped to the present commonly deleted region. In addition, we have excluded a previously known TSG PPP2R1B at 11q23 as a deletion target in CC. The definition of the minimal deletion and the availability of expressed sequence resources should facilitate the identification of the candidate TSG.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118052

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages.

Authors:  Amy J Murphy; Paul M Guyre; Patricia A Pioli
Journal:  J Immunol       Date:  2010-03-29       Impact factor: 5.422

2.  Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond.

Authors:  Helen J Mackay; Lari Wenzel; Linda Mileshkin
Journal:  Am Soc Clin Oncol Educ Book       Date:  2015

3.  Alterations of ATM and CADM1 in chromosomal 11q22.3-23.2 region are associated with the development of invasive cervical carcinoma.

Authors:  Dipanjana Mazumder Indra; Sraboni Mitra; Anup Roy; Ranajit Kumar Mondal; Partha Sarathi Basu; Susanta Roychoudhury; Runu Chakravarty; Chinmay Kumar Panda
Journal:  Hum Genet       Date:  2011-06-05       Impact factor: 4.132

4.  Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer.

Authors:  Hugo Arias-Pulido; Cheri L Peyton; Nancy E Joste; Hernan Vargas; Cosette M Wheeler
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

5.  Deletion in chromosome 11 and Bcl-1/Cyclin D1 alterations are independently associated with the development of uterine cervical carcinoma.

Authors:  Ratnesh Kumar Singh; Santanu Dasgupta; Nilanjana Bhattacharya; Neelanjana Chunder; Ranjit Mondal; Anup Roy; Syamsundar Mandal; Susanta Roychowdhury; Chinmay Kumar Panda
Journal:  J Cancer Res Clin Oncol       Date:  2005-03-15       Impact factor: 4.553

6.  Allelic imbalance at chromosome 11 in head and neck squamous cell carcinoma in an Indian patient population.

Authors:  G Mondal; A Tripathi; N Bhattacharya; N Sikdar; A Roy; A Sengupta; B Roy; C K Panda; S Roychoudhury
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

7.  The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene.

Authors:  Eric S Martin; Rossano Cesari; Francesca Pentimalli; Kristine Yoder; Richard Fishel; Andrew L Himelstein; S Eric Martin; Andrew K Godwin; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

8.  LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer.

Authors:  D C T Ong; Y M Ho; C Rudduck; K Chin; W-L Kuo; D K H Lie; C L M Chua; P H Tan; K W Eu; F Seow-Choen; C Y Wong; G S Hong; J W Gray; A S G Lee
Journal:  Oncogene       Date:  2009-09-07       Impact factor: 9.867

9.  Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression.

Authors:  Gopeshwar Narayan; Chandra Goparaju; Hugo Arias-Pulido; Andreas M Kaufmann; Achim Schneider; Matthias Dürst; Mahesh Mansukhani; Bhavana Pothuri; Vundavalli V Murty
Journal:  Mol Cancer       Date:  2006-05-15       Impact factor: 27.401

10.  Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome.

Authors:  Gopeshwar Narayan; Hugo Arias-Pulido; Sanjay Koul; Hernan Vargas; Fang F Zhang; Jeannine Villella; Achim Schneider; Mary B Terry; Mahesh Mansukhani; Vundavalli V Murty
Journal:  Mol Cancer       Date:  2003-05-13       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.